On the public citation graph

Lysine-Restricted Diet as Adjunct Therapy for Pyridoxine-Dependent Epilepsy: The PDE Consortium Consensus Recommendations

https://doi.org/10.1007/8904_2014_296

0 signed · 83 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.

Claim with ORCID

Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.

See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/ana.22095openalex-snapshot

Use of guidelines improves the neurological outcome in glutaric aciduria type I

inferredcites →https://doi.org/10.1002/ana.24027openalex-snapshot

Glial localization of antiquitin: Implications for pyridoxine‐dependent epilepsy

inferredcites →https://doi.org/10.1007/bf01958419openalex-snapshot

Pyridoxine-dependent seizures, clinical and therapeutic aspects

inferredcites →https://doi.org/10.1007/s00431-008-0823-xopenalex-snapshot

Clinical features and the management of pyridoxine-dependent and pyridoxine-responsive seizures: review of 63 North American cases submitted to a patient registry

inferredcites →https://doi.org/10.1007/s10545-011-9289-5openalex-snapshot

Diagnosis and management of glutaric aciduria type I – revised recommendations

inferredcites →https://doi.org/10.1007/s10545-012-9455-4openalex-snapshot

Cultural aspects in the management of inborn errors of metabolism

inferredcites →https://doi.org/10.1007/s10545-012-9466-1openalex-snapshot

Urinary AASA excretion is elevated in patients with molybdenum cofactor deficiency and isolated sulphite oxidase deficiency

inferredcites →https://doi.org/10.1007/s10545-012-9493-yopenalex-snapshot

Measurement of plasma B6 vitamer profiles in children with inborn errors of vitamin B6 metabolism using an LC‐MS/MS method

inferredcites →https://doi.org/10.1016/j.ymgme.2011.05.014openalex-snapshot

Pyridoxine dependent epilepsy and antiquitin deficiency

inferredcites →https://doi.org/10.1016/j.ymgme.2011.07.003openalex-snapshot

Safety, efficacy and physiological actions of a lysine-free, arginine-rich formula to treat glutaryl-CoA dehydrogenase deficiency: Focus on cerebral amino acid influx

inferredcites →https://doi.org/10.1016/j.ymgme.2012.03.021openalex-snapshot

Complementary dietary treatment using lysine-free, arginine-fortified amino acid supplements in glutaric aciduria type I — A decade of experience

inferredcites →https://doi.org/10.1016/j.ymgme.2012.09.006openalex-snapshot

Lysine restricted diet for pyridoxine-dependent epilepsy: First evidence and future trials

inferredcites →https://doi.org/10.1016/j.ymgme.2013.04.018openalex-snapshot

Normal plasma pipecolic acid level in pyridoxine dependent epilepsy due to ALDH7A1 mutations

inferredcites →https://doi.org/10.1016/j.ymgme.2013.07.017openalex-snapshot

Preliminary investigation of the use of newborn dried blood spots for screening pyridoxine-dependent epilepsy by LC-MS/MS

inferredcites →https://doi.org/10.1017/s0007114599000082openalex-snapshot

Non-nutritional uses of vitamin B6

inferredcites →https://doi.org/10.1017/s0012162201000779openalex-snapshot

Pyridoxine-dependent and pyridoxine-responsive seizures

inferredcites →https://doi.org/10.1038/nm1366openalex-snapshot

Mutations in antiquitin in individuals with pyridoxine-dependent seizures

inferredcites →https://doi.org/10.1093/brain/awq143openalex-snapshot

Genotypic and phenotypic spectrum of pyridoxine-dependent epilepsy (ALDH7A1 deficiency)

inferredcites →https://doi.org/10.1111/j.1469-8749.2012.04347.xopenalex-snapshot

Long‐term outcome in pyridoxine‐dependent epilepsy

inferredcites →https://doi.org/10.1111/j.1469-8749.2012.04354.xopenalex-snapshot

Natural history of pyridoxine‐dependent epilepsy: tools for prognostication

inferredcites →https://doi.org/10.1136/fn.81.2.f125openalex-snapshot

Pyridoxine dependent epilepsy: a suggestive electroclinical pattern

inferredcites →https://doi.org/10.1203/01.pdr.0000219387.79887.86openalex-snapshot

Natural History, Outcome, and Treatment Efficacy in Children and Adults with Glutaryl-CoA Dehydrogenase Deficiency

inferredcites →https://doi.org/10.4324/9780429036279-4openalex-snapshot

Energy and protein requirements*

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4585169openalex-extracted

Partial Suppression of Bcaa Catabolism as a Potential Therapy for Bckdk Deficiency

inferred← citeshttps://doi.org/10.2139/ssrn.4670032openalex-extracted

Partial Suppression of BCAA Catabolism as a Potential Therapy for BCKDK Deficiency

inferred← citeshttps://doi.org/10.1002/ajmg.a.61815openalex-snapshot

A cautionary tale of pyridoxine toxicity in cystathionine beta‐synthase deficiency detected by two‐tier newborn screening highlights the need for clear pyridoxine dosing guidelines

inferred← citeshttps://doi.org/10.1002/cns3.20016openalex-snapshot

Pyridoxine‐dependent epilepsy: Current perspectives and questions for future research

inferred← citeshttps://doi.org/10.1002/jimd.12233openalex-snapshot

Impact of enteral arginine supplementation on lysine metabolism in humans: A proof‐of‐concept for lysine‐related inborn errors of metabolism

inferred← citeshttps://doi.org/10.1002/jimd.12332openalex-snapshot

Consensus guidelines for the diagnosis and management of pyridoxine‐dependent epilepsy due to α‐aminoadipic semialdehyde dehydrogenase deficiency

inferred← citeshttps://doi.org/10.1002/jmd2.12418openalex-snapshot

Dietary management for pyridoxine‐dependent epilepsy due to α‐aminoadipic semialdehyde dehydrogenase deficiency, a follow‐on from the international consortium guidelines

inferred← citeshttps://doi.org/10.1002/mgg3.355openalex-snapshot

Integrating exome sequencing into a diagnostic pathway for epileptic encephalopathy: Evidence of clinical utility and cost effectiveness

inferred← citeshttps://doi.org/10.1007/978-3-030-02992-0_3openalex-snapshot

Medical Issues, Therapies, and Treatments

inferred← citeshttps://doi.org/10.1007/978-3-030-67727-5_34openalex-snapshot

Vitamin B6-Dependent and Vitamin B6-Responsive Disorders

inferred← citeshttps://doi.org/10.1007/978-3-662-43751-3openalex-snapshot

JIMD Reports - Case and Research Reports, Volume 15

inferred← citeshttps://doi.org/10.1007/s11011-016-9869-zopenalex-snapshot

Pyridoxine-dependent epilepsy: report on three families with neuropathology

inferred← citeshttps://doi.org/10.1007/s11011-016-9933-8openalex-snapshot

Phenotype, biochemical features, genotype and treatment outcome of pyridoxine-dependent epilepsy

inferred← citeshttps://doi.org/10.1007/s11940-014-0335-0openalex-snapshot

Current Treatment and Management of Pyridoxine-Dependent Epilepsy

inferred← citeshttps://doi.org/10.1007/s12098-020-03510-wopenalex-snapshot

Metabolic Epilepsy

inferred← citeshttps://doi.org/10.1007/s13760-020-01467-3openalex-snapshot

Clinical and biochemical outcome of a patient with pyridoxine-dependent epilepsy treated by triple therapy (pyridoxine supplementation, lysine-restricted diet, and arginine supplementation)

inferred← citeshttps://doi.org/10.1016/b978-0-12-410529-4.00049-8openalex-snapshot

Disorders of Pyridoxine Metabolism

inferred← citeshttps://doi.org/10.1016/b978-0-12-813955-4.00053-2openalex-snapshot

Disorders of pyridoxine metabolism

inferred← citeshttps://doi.org/10.1016/b978-0-443-19176-3.00062-5openalex-snapshot

Disorders of pyridoxine metabolism

inferred← citeshttps://doi.org/10.1016/j.cdnut.2025.107504openalex-snapshot

Combination Therapy with Pyridoxine and Arginine Supplementations along with a Lysine-Restricted Diet in Individuals with Pyridoxine-Dependent Epilepsy: A Comprehensive Systematic Review

inferred← citeshttps://doi.org/10.1016/j.celrep.2024.115069openalex-snapshot

Restricting lysine normalizes toxic catabolites associated with ALDH7A1 deficiency in cells and mice

inferred← citeshttps://doi.org/10.1016/j.ejpn.2015.08.001openalex-snapshot

Long-term outcome in pyridoxine-responsive infantile epilepsy

inferred← citeshttps://doi.org/10.1016/j.ejpn.2021.06.001openalex-snapshot

Cognitive and neurological outcome of patients in the Dutch pyridoxine-dependent epilepsy (PDE-ALDH7A1) cohort, a cross-sectional study

inferred← citeshttps://doi.org/10.1016/j.ijantimicag.2025.107511openalex-snapshot

Restoring tigecycline efficacy with lysine supplementation in tmexCD-toprJ-positive bacteria

inferred← citeshttps://doi.org/10.1016/j.jchromb.2016.02.043openalex-snapshot

A novel method for simultaneous quantification of alpha-aminoadipic semialdehyde/piperideine-6-carboxylate and pipecolic acid in plasma and urine

inferred← citeshttps://doi.org/10.1016/j.neubiorev.2020.06.010openalex-snapshot

Seizing the moment: Zebrafish epilepsy models

inferred← citeshttps://doi.org/10.1016/j.pediatrneurol.2015.12.013openalex-snapshot

Pyridoxine-Dependent Epilepsy: An Expanding Clinical Spectrum

inferred← citeshttps://doi.org/10.1016/j.pediatrneurol.2016.03.008openalex-snapshot

A Prospective Case Study of the Safety and Efficacy of Lysine-Restricted Diet and Arginine Supplementation Therapy in a Patient With Pyridoxine-Dependent Epilepsy Caused by Mutations in ALDH7A1

inferred← citeshttps://doi.org/10.1016/j.spen.2016.06.004openalex-snapshot

Amenable Treatable Severe Pediatric Epilepsies

inferred← citeshttps://doi.org/10.1016/j.spen.2025.101204openalex-snapshot

Genetic testing for infantile-onset epilepsies in resource-limited settings

inferred← citeshttps://doi.org/10.1016/j.yebeh.2023.109363openalex-snapshot

Update current understanding of neurometabolic disorders related to lysine metabolism

inferred← citeshttps://doi.org/10.1016/j.ymgme.2015.03.001openalex-snapshot

Retrospective analysis supports algorithm as efficient diagnostic approach to treatable intellectual developmental disabilities

inferred← citeshttps://doi.org/10.1016/j.ymgme.2015.05.011openalex-snapshot

Triple therapy with pyridoxine, arginine supplementation and dietary lysine restriction in pyridoxine-dependent epilepsy: Neurodevelopmental outcome

inferred← citeshttps://doi.org/10.1016/j.ymgme.2015.12.007openalex-snapshot

Metabolic Diet App Suite for inborn errors of amino acid metabolism

inferred← citeshttps://doi.org/10.1016/j.ymgme.2016.04.015openalex-snapshot

Effect of dietary lysine restriction and arginine supplementation in two patients with pyridoxine-dependent epilepsy

inferred← citeshttps://doi.org/10.1016/j.ymgmr.2024.101091openalex-snapshot

Partial suppression of BCAA catabolism as a potential therapy for BCKDK deficiency

inferred← citeshttps://doi.org/10.1021/acssynbio.5c00725openalex-snapshot

Rapid Phenotypic Screening of Lysine-Degrading Probiotics via FTIR Spectroscopy: Toward Precision Therapy for Hyperlysinemia

inferred← citeshttps://doi.org/10.1055/s-0037-1621721openalex-snapshot

Antiquitin Deficiency with Adolescent Onset Epilepsy: Molecular Diagnosis in a Mother of Affected Offsprings

inferred← citeshttps://doi.org/10.1055/s-0045-1808381openalex-snapshot

Status epilepticus nach Asphyxie als diagnostische Herausforderung: Antiquitin-Mangel als seltene Differentialdiagnose

inferred← citeshttps://doi.org/10.1080/14737175.2019.1648212openalex-snapshot

Update on the treatment of vitamin B6 dependent epilepsies

inferred← citeshttps://doi.org/10.1080/14737175.2021.1885374openalex-snapshot

Managing CLN2 disease: a treatable neurodegenerative condition among other treatable early childhood epilepsies

inferred← citeshttps://doi.org/10.1080/17446651.2017.1273107openalex-snapshot

Current knowledge for pyridoxine-dependent epilepsy: a 2016 update

inferred← citeshttps://doi.org/10.1080/23808993.2018.1486189openalex-snapshot

Personalized treatment in the epilepsies: challenges and opportunities

inferred← citeshttps://doi.org/10.1093/hmg/ddaa202openalex-snapshot

A novel mouse model for pyridoxine-dependent epilepsy due to antiquitin deficiency

inferred← citeshttps://doi.org/10.1101/2024.09.03.24312979openalex-snapshot

Evaluating whole genome sequencing for rare diseases in newborn screening: evidence synthesis from a series of systematic reviews

inferred← citeshttps://doi.org/10.1101/mcs.a006197openalex-snapshot

A case for newborn screening for pyridoxine-dependent epilepsy

inferred← citeshttps://doi.org/10.1111/epi.16408openalex-snapshot

Diagnosis of pyridoxine‐dependent epilepsy in an adult presenting with recurrent status epilepticus

inferred← citeshttps://doi.org/10.1155/2019/2893041openalex-snapshot

Metagenomics and Faecal Metabolomics Integrative Analysis towards the Impaired Glucose Regulation and Type 2 Diabetes in Uyghur-Related Omics

inferred← citeshttps://doi.org/10.1186/s12883-024-03936-1openalex-snapshot

Pyridoxine-dependent epilepsy caused by an ALDH7A1 mutation in an infant girl: the first case report in Syria

inferred← citeshttps://doi.org/10.1212/wnl.0000000000005748openalex-snapshot

Geometric morphometrics reveal altered corpus callosum shape in pyridoxine-dependent epilepsy

inferred← citeshttps://doi.org/10.1212/wnl.0000000000201222openalex-snapshot

Association Between Lysine Reduction Therapies and Cognitive Outcomes in Patients With Pyridoxine-Dependent Epilepsy

inferred← citeshttps://doi.org/10.1371/journal.pone.0186645openalex-snapshot

Characterization of the first knock-out aldh7a1 zebrafish model for pyridoxine-dependent epilepsy using CRISPR-Cas9 technology

inferred← citeshttps://doi.org/10.15761/ndt.1000109openalex-snapshot

Refractory seizures in a term neonate due to pyridoxine dependent epilepsy

inferred← citeshttps://doi.org/10.20966/chn.2016.51.385openalex-snapshot

Current diagnosis and treatment of pyridoxine dependent epilepsy due to antiqutin deficiency

inferred← citeshttps://doi.org/10.2174/011573398x289178240528052344openalex-snapshot

Respiratory Complications in the Inborn Errors of Metabolism

inferred← citeshttps://doi.org/10.26815/acn.2022.00122openalex-snapshot

A Patient with Pyridoxine-Dependent Epilepsy Who Was Treated with Triple Therapy

inferred← citeshttps://doi.org/10.3390/brainsci12010065openalex-snapshot

Pyridoxine-Dependent Epilepsy and Antiquitin Deficiency Resulting in Neonatal-Onset Refractory Seizures

inferred← citeshttps://doi.org/10.3410/f.732440288.793555817openalex-snapshot

Faculty Opinions recommendation of Integrating exome sequencing into a diagnostic pathway for epileptic encephalopathy: Evidence of clinical utility and cost effectiveness.

inferred← citeshttps://doi.org/10.4103/aian.aian_204_19openalex-snapshot

Pyridoxine trial in early infantile epileptic encephalopathy: Never forget!

inferred← citeshttps://doi.org/10.4103/jpn.jpn_160_16openalex-snapshot

Actual insights into treatable inborn errors of metabolism causing epilepsy

Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.